Manufacturers Life Insurance Company, The Bio Atla, Inc. Transaction History

Manufacturers Life Insurance Company, The

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.88 - $3.46 $25,195 - $46,370	13,402 New	13,402 $46,000
Q3 2023 Nov 15, 2023	SELL	$1.7 - $3.07 $13,722 - $24,781	-8,072 Reduced 41.63%	11,317 $19,000
Q2 2023 Aug 11, 2023	BUY	$2.83 - $3.87 $54,870 - $75,035	19,389 New	19,389 $58,000
Q4 2021 Feb 16, 2022	SELL	$19.0 - $30.95 $158,403 - $258,030	-8,337 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$29.44 - $43.74 $39,744 - $59,049	1,350 Added 19.32%	8,337 $245,000
Q2 2021 Aug 12, 2021	BUY	$38.07 - $56.17 $23,603 - $34,825	620 Added 9.74%	6,987 $296,000
Q1 2021 May 03, 2021	BUY	$32.41 - $70.91 $206,354 - $451,483	6,367 New	6,367 $324,000

17.3M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $62.4M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.